The China Drug Delivery market is projected to grow at a CAGR of 9.65% to reach US$ 93.788 billion by 2024, from US$ 53.971 billion in 2018. The drug delivery market in China is poised to grow at a fast pace owing to high growth of Pharma Industry here, a rapidly aging population and prevalence of chronic diseases. Furthermore, growing health expenditure is augmenting the market growth during the forecast period. In the end, growing innovations in drug delivery will provide an opportunity for the growth of the China drug delivery market in the forecast period and beyond.
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the China Drug Delivery value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the China Drug Delivery market.
Major industry players profiled as part of the report are AstraZeneca group companies, West Pharmaceutical Services, Inc., Becton, Dickinson and Company, Medtronic, and Boston Scientific Corporation.
Segmentation
The China Drug Delivery market has been analyzed through following segments:
By Type
Inhalation Drug Delivery
Injectable Drug Delivery
Nasal Drug Delivery
Oral Drug Delivery
Transdermal Drug Delivery
By Application
Treatment of diseases
Research/Academic purposes
Target audience
Manufacturers
Suppliers
Distributors
Service Providers
Government Agencies
Research Organizations
Consultants
Key insights offered
What will be the China Drug Delivery market size from 2018 to 2024?
How are the major drivers and restraints affecting the China Drug Delivery market growth and the opportunities which exist for key vendors?
Which segment and region will drive or lead the market growth and why?
A comprehensive analysis of competitive landscape and key market participants’ behaviour
Key strategies being adopted by vendors, with in-depth analysis along with their impact on competition and market growth.
.jpg)
